Codiak Biosciences Funding: $169M Raised, Series B (2016)

Codiak Biosciences funding overview

Codiak Biosciences is based in Boston. Codiak Biosciences has raised $169M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2016. The round record for Codiak Biosciences runs through 2016; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Flagship Ventures, Alaska Permanent Fund, Alexandria Venture Investments, Fidelity. 5 distinct backers are named across the disclosed rounds.

Codiak Biosciences at a glance

Total raised: $169M
Latest round: Series B
Latest round date: January 2016
Headquarters: Boston
Notable investors: ARCH Venture Partners, Flagship Ventures, Alaska Permanent Fund, Alexandria Venture Investments, Fidelity

Frequently asked about Codiak Biosciences funding

How much has Codiak Biosciences raised?: Codiak Biosciences has raised $169M in total disclosed funding across the rounds on record.
Who has invested in Codiak Biosciences?: ARCH Venture Partners, Flagship Ventures, Alaska Permanent Fund, Alexandria Venture Investments, Fidelity are named among the investors backing Codiak Biosciences.
What was the latest Codiak Biosciences funding round?: The most recent disclosed round is a Series B, announced in January 2016.
Where is Codiak Biosciences based?: Codiak Biosciences is based in Boston.
When did Codiak Biosciences last raise?: The last disclosed Codiak Biosciences round closed in January 2016 at Series B.

Codiak Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Codiak Biosciences Funding: $169M Raised, Series B (2016)

Codiak Biosciences funding overview

Codiak Biosciences at a glance

Frequently asked about Codiak Biosciences funding

Companies related to Codiak Biosciences (36)

Browse related funding lists (7)